Clinical Trial Update: TF for the Prediction of Visual Field Progression [NA]

View source ↗

Summary

The clinical trial NCT03047239 evaluating TF for predicting visual field progression in open-angle glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Snippet

Sponsor: Sensimed AG | Conditions: Open Angle Glaucoma | NA | Status: WITHDRAWN